The clinical approach toward giant cell tumor of bone

L Van der Heijden, PDS Dijkstra… - The …, 2014 - academic.oup.com
We provide an overview of imaging, histopathology, genetics, and multidisciplinary
treatment of giant cell tumor of bone (GCTB), an intermediate, locally aggressive but rarely …

Sarcoma

KM Skubitz, DR D'Adamo - Mayo Clinic Proceedings, 2007 - Elsevier
Sarcomas comprise a heterogeneous group of mesenchymal neoplasms. They can be
grouped into 2 general categories, soft tissue sarcoma and primary bone sarcoma, which …

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone

P Rutkowski, S Ferrari, RJ Grimer, PD Stalley… - Annals of surgical …, 2015 - Springer
Background Surgical resection with curative intent for giant cell tumor of bone (GCTB) may
be associated with severe morbidity. This interim analysis evaluated reduction in surgical …

Osteonecrosis of the jaw in a patient on Denosumab

TL Aghaloo, AL Felsenfeld, S Tetradis - Journal of Oral and Maxillofacial …, 2010 - joms.org
Osteonecrosis of the jaw (ONJ) presents clinically as exposed, necrotic bone in the maxilla
or mandible of at least 8 weeks' duration, with or without the presence of pain, infection, or …

Giant cell tumour of bone: morphological, biological and histogenetical aspects

M Werner - International orthopaedics, 2006 - Springer
The giant cell tumour of bone (GCT) is a locally aggressive intraosseous neoplasm of
obscure biological behaviour. Although well defined in clinical, radiological and histological …

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice

M Kansara, M Tsang, L Kodjabachian… - The Journal of …, 2009 - Am Soc Clin Investig
Wnt signaling increases bone mass by stimulating osteoblast lineage commitment and
expansion and forms the basis for novel anabolic therapeutic strategies being developed for …

Giant cell tumor of bone: a basic science perspective

RW Cowan, G Singh - Bone, 2013 - Elsevier
Comprehending the pathogenesis of giant cell tumor of bone (GCT) is of critical importance
for developing novel targeted treatments for this locally-aggressive primary bone tumor. GCT …

Giant cell tumour of bone

DM Thomas, KM Skubitz - Current opinion in oncology, 2009 - journals.lww.com
Giant cell tumour of bone : Current Opinion in Oncology Giant cell tumour of bone : Current
Opinion in Oncology Log in or Register Subscribe to journalSubscribe Get new issue alertsGet …

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone–multicenter analysis outside clinical trial

P Rutkowski, L Gaston, A Borkowska… - European Journal of …, 2018 - Elsevier
Background Giant cell tumor of bone (GCTB) is an osteolytic, locally aggressive, rarely
metastazing bone tumor. This is a retrospective study evaluating a large series of GCTB …

Giant cell tumour of bone: new treatments in development

A López-Pousa, JM Broto, T Garrido… - Clinical and Translational …, 2015 - Springer
Giant cell tumour of bone (GCTB) is a benign osteolytic tumour with three main cellular
components: multinucleated osteoclast-like giant cells, mononuclear spindle-like stromal …